Zymeworks Inc. Common Stock (ZYME) — Cash Flow-to-Debt Ratio
Zymeworks Inc. Common Stock (ZYME) has a Cash Flow-to-Debt Ratio of -0.41x as of September 2025, meaning its operating cash flow of $-31.41 Million could theoretically repay 0% of its total liabilities ($77.20 Million) in one year. Explore Zymeworks Inc. Common Stock long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zymeworks Inc. Common Stock Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Zymeworks Inc. Common Stock across 11 annual periods. Also explore total assets of Zymeworks Inc. Common Stock for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zymeworks Inc. Common Stock (2014–2024)
Year-by-year debt coverage analysis for Zymeworks Inc. Common Stock. For market capitalisation and broader financial context, see ZYME stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.89x | $-110.04 Million | $124.32 Million | ▲ +13.2% |
| 2023 | -1.02x | $-118.30 Million | $116.07 Million | ▼ -210.2% |
| 2022 | 0.93x | $144.11 Million | $155.77 Million | ▲ +167.3% |
| 2021 | -1.37x | $-192.45 Million | $140.04 Million | ▼ -16.6% |
| 2020 | -1.18x | $-151.40 Million | $128.45 Million | ▼ -76.4% |
| 2019 | -0.67x | $-81.85 Million | $122.52 Million | ▼ -276.5% |
| 2018 | 0.38x | $24.18 Million | $63.87 Million | ▲ +2583.7% |
| 2017 | 0.01x | $219.00K | $15.53 Million | ▲ +103.4% |
| 2016 | -0.41x | $-35.25 Million | $84.99 Million | ▲ +90.8% |
| 2015 | -4.52x | $-22.17 Million | $4.91 Million | ▼ -601.8% |
| 2014 | -0.64x | $-7.02 Million | $10.90 Million | — |